The adeno-associated virus (AAV)-mediated single administration of micro-dystrophin (e.g., SRP-9001, PF-06939926, and SGT-001) is still being evaluated in several clinical studies involving DMD boys (http://clinicaltrials.gov). The gene discussed is DMD; the disease is Duchenne muscular dystrophy.